Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania. (2014)
Attributed to:
Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2013.11.061
PubMed Identifier: 24291193
Publication URI: http://europepmc.org/abstract/MED/24291193
Type: Journal Article/Review
Volume: 32
Parent Publication: Vaccine
Issue: 5
ISSN: 0264-410X